Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced participation at several upcoming investor conferences.

Details of each presentation are as follows:

Cowen 2nd Annual Genetic Medicines Summit Panel: Gene Therapies - Clinical Topics Date: Thursday, February 3, 2022 Time: 12:00 p.m. ET

SVB Leerink Global Healthcare Conference Company Presentation Date: Friday, February 18, 2022 Time: 3:40 p.m. ET

Cowen 42nd Annual Health Care Conference Panel: Gene Therapy Date: Wednesday March 9, 2022 Time: 12:50 p.m. ET

About Tenaya Therapeutics

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.

Investors Leone Patterson Tenaya Therapeutics IR@tenayathera.com

Media Wendy Ryan Ten Bridge Communications Wendy@tenbridgecommunications.com

Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Tenaya Therapeutics Charts.
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Tenaya Therapeutics Charts.